We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Less Than 40 Percent of U.S. Registered Trials in Reporting Compliance, Analysis Finds
Less Than 40 Percent of U.S. Registered Trials in Reporting Compliance, Analysis Finds
Less than 40 percent of clinical trials active in ClinicalTrials.gov over the past four years were in compliance with FDA reporting requirements, a new analysis of the federal database revealed.